Application Nr Approved Date Route Status External Links
NDA019937 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Intravenous Adenocard (adenosine Injection) Is Indicated For The Following. Conversion To Sinus Rhythm Of Paroxysmal Supraventricular Tachycardia (psvt), Including That Associated With Accessory Bypass Tracts (wolff-Parkinson-White Syndrome). When Clinically Advisable, Appropriate Vagal Maneuvers (e.g., Valsalva Maneuver), Should Be Attempted Prior To Adenocard Administration. It Is Important To Be Sure The Adenocard Solution Actually Reaches The Systemic Circulation (see Dosage And Administration ). Adenocard Does Not Convert Atrial Flutter, Atrial Fibrillation, Or Ventricular Tachycardia To Normal Sinus Rhythm. In The Presence Of Atrial Flutter Or Atrial Fibrillation, A Transient Modest Slowing Of Ventricular Response May Occur Immediately Following Adenocard Administration.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Adenosine ADENOSINE ZINC2169830

Comments